Financials

  • Market Capitalization 353.61 M
  • Employee 161
  • Founded 2018
  • CEO N/A
  • Website www.lyell.com
  • Headquarter Delaware, United States
  • FIGI BBG00RNXFN14
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.11
Fiyat/satışlar oranı
9 792.6

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3118
CTNM
Contineum Therapeutics, Inc. - Common stock
16.47 USD-3.40%-3.51%+8.21%+7.86%380.44 M USD
3137
IPSC
Century Therapeutics, Inc. - Common Stock
2.03 USD0.00%-3.79%-0.98%+314.29%367.58 M USD
3191
FHTX
Foghorn Therapeutics Inc. - Common Stock
5.81 USD-3.17%-16.04%+27.69%+42.40%345.03 M USD
3192
AGEN
Agenus Inc. - Common Stock
7.63 USD-0.39%-1.04%-0.26%+84.75%343.51 M USD

Haberler